Bcl: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{PAGENAME}} - human cyclin d1 (bcl1) proto oncogene, located at 11q13, encodes g1/s specific cyclin d1 (ccnd1) protein. Bcl1 gene expression is activated in human b cell lymphomas by translocation, t(11;14)(q13;q32), with immunoglobulin gene regions. Enhanced expression of cyclin d1 protein has also been detected in parathyroid adenomas due to a translocation, t(11;11)(q13;p15), resulting in fusion of bcl1 with the parathyroid hormone enhancer.
{{DISPLAYTITLE:Bcl-2 Family Proteins}}
{{med-stub}}
{{Infobox protein family
{{dictionary-stub2}}
| Name = Bcl-2 family
{{short-articles-ni}}
| Image = Bcl-2 protein structure.png
| Caption = Structure of Bcl-2 protein
| Symbol = BCL2
| Pfam = PF00452
| Interpro = IPR002475
}}
 
The '''Bcl-2 family''' of proteins is a group of evolutionarily conserved proteins that play a crucial role in the regulation of [[apoptosis]], or programmed cell death. These proteins are key regulators of the mitochondrial pathway of apoptosis and are involved in maintaining the balance between cell survival and cell death.
 
==Structure==
The Bcl-2 family proteins are characterized by the presence of one or more Bcl-2 homology (BH) domains. These domains are critical for the protein-protein interactions that determine the pro-apoptotic or anti-apoptotic function of the family members. The family is divided into three main groups based on their function and structure:
 
===Anti-apoptotic Members===
Anti-apoptotic proteins, such as [[Bcl-2]], [[Bcl-xL]], and [[Mcl-1]], contain four BH domains (BH1, BH2, BH3, and BH4). These proteins function to inhibit apoptosis by binding to and sequestering pro-apoptotic members of the family, thereby preventing the release of cytochrome c from the mitochondria.
 
===Pro-apoptotic Members===
Pro-apoptotic proteins are further divided into two subgroups:
 
====Multidomain Pro-apoptotic Proteins====
This subgroup includes proteins such as [[Bax]] and [[Bak]], which contain three BH domains (BH1, BH2, and BH3). These proteins promote apoptosis by forming pores in the mitochondrial outer membrane, leading to the release of apoptogenic factors.
 
====BH3-only Proteins====
BH3-only proteins, such as [[Bid]], [[Bim]], [[Puma]], and [[Noxa]], contain only the BH3 domain. They act as initiators of apoptosis by binding to and neutralizing anti-apoptotic proteins, thereby activating Bax and Bak.
 
==Function==
The primary function of the Bcl-2 family proteins is to regulate the mitochondrial pathway of apoptosis. This pathway is initiated in response to various cellular stresses, such as DNA damage, growth factor deprivation, and oxidative stress.
 
===Regulation of Mitochondrial Outer Membrane Permeabilization (MOMP)===
The balance between pro-apoptotic and anti-apoptotic Bcl-2 family members determines the permeability of the mitochondrial outer membrane. When pro-apoptotic signals predominate, Bax and Bak oligomerize and form pores in the membrane, leading to MOMP and the release of cytochrome c and other apoptogenic factors into the cytosol.
 
===Cytochrome c Release and Apoptosome Formation===
Once released into the cytosol, cytochrome c binds to [[Apaf-1]] and [[caspase-9]], forming the apoptosome. This complex activates downstream effector caspases, such as caspase-3, leading to the execution phase of apoptosis.
 
==Role in Disease==
Dysregulation of Bcl-2 family proteins is implicated in various diseases, particularly [[cancer]]. Overexpression of anti-apoptotic members, such as Bcl-2, is commonly observed in cancer cells, contributing to their resistance to apoptosis and promoting tumorigenesis. Conversely, loss of pro-apoptotic members can also lead to impaired apoptosis and cancer progression.
 
===Therapeutic Targeting===
Given their critical role in apoptosis regulation, Bcl-2 family proteins are attractive targets for cancer therapy. Small molecule inhibitors, such as [[venetoclax]], have been developed to specifically target and inhibit anti-apoptotic Bcl-2 proteins, restoring the apoptotic potential of cancer cells.
 
==Conclusion==
The Bcl-2 family of proteins is essential for the regulation of apoptosis, with significant implications for both normal physiology and disease. Understanding the intricate balance between pro-apoptotic and anti-apoptotic signals is crucial for developing therapeutic strategies to modulate apoptosis in various pathological conditions.
 
{{Protein families}}
[[Category:Apoptosis]]
[[Category:Protein families]]
[[Category:Oncology]]

Latest revision as of 17:15, 1 January 2025


The Bcl-2 family of proteins is a group of evolutionarily conserved proteins that play a crucial role in the regulation of apoptosis, or programmed cell death. These proteins are key regulators of the mitochondrial pathway of apoptosis and are involved in maintaining the balance between cell survival and cell death.

Structure[edit]

The Bcl-2 family proteins are characterized by the presence of one or more Bcl-2 homology (BH) domains. These domains are critical for the protein-protein interactions that determine the pro-apoptotic or anti-apoptotic function of the family members. The family is divided into three main groups based on their function and structure:

Anti-apoptotic Members[edit]

Anti-apoptotic proteins, such as Bcl-2, Bcl-xL, and Mcl-1, contain four BH domains (BH1, BH2, BH3, and BH4). These proteins function to inhibit apoptosis by binding to and sequestering pro-apoptotic members of the family, thereby preventing the release of cytochrome c from the mitochondria.

Pro-apoptotic Members[edit]

Pro-apoptotic proteins are further divided into two subgroups:

Multidomain Pro-apoptotic Proteins[edit]

This subgroup includes proteins such as Bax and Bak, which contain three BH domains (BH1, BH2, and BH3). These proteins promote apoptosis by forming pores in the mitochondrial outer membrane, leading to the release of apoptogenic factors.

BH3-only Proteins[edit]

BH3-only proteins, such as Bid, Bim, Puma, and Noxa, contain only the BH3 domain. They act as initiators of apoptosis by binding to and neutralizing anti-apoptotic proteins, thereby activating Bax and Bak.

Function[edit]

The primary function of the Bcl-2 family proteins is to regulate the mitochondrial pathway of apoptosis. This pathway is initiated in response to various cellular stresses, such as DNA damage, growth factor deprivation, and oxidative stress.

Regulation of Mitochondrial Outer Membrane Permeabilization (MOMP)[edit]

The balance between pro-apoptotic and anti-apoptotic Bcl-2 family members determines the permeability of the mitochondrial outer membrane. When pro-apoptotic signals predominate, Bax and Bak oligomerize and form pores in the membrane, leading to MOMP and the release of cytochrome c and other apoptogenic factors into the cytosol.

Cytochrome c Release and Apoptosome Formation[edit]

Once released into the cytosol, cytochrome c binds to Apaf-1 and caspase-9, forming the apoptosome. This complex activates downstream effector caspases, such as caspase-3, leading to the execution phase of apoptosis.

Role in Disease[edit]

Dysregulation of Bcl-2 family proteins is implicated in various diseases, particularly cancer. Overexpression of anti-apoptotic members, such as Bcl-2, is commonly observed in cancer cells, contributing to their resistance to apoptosis and promoting tumorigenesis. Conversely, loss of pro-apoptotic members can also lead to impaired apoptosis and cancer progression.

Therapeutic Targeting[edit]

Given their critical role in apoptosis regulation, Bcl-2 family proteins are attractive targets for cancer therapy. Small molecule inhibitors, such as venetoclax, have been developed to specifically target and inhibit anti-apoptotic Bcl-2 proteins, restoring the apoptotic potential of cancer cells.

Conclusion[edit]

The Bcl-2 family of proteins is essential for the regulation of apoptosis, with significant implications for both normal physiology and disease. Understanding the intricate balance between pro-apoptotic and anti-apoptotic signals is crucial for developing therapeutic strategies to modulate apoptosis in various pathological conditions.

Template:Protein families